skip to main content
Give

Core News & Events

NEWS

🌟 Exciting News! We've Moved to a State-of-the-Art Location! 🌟

We are thrilled to announce that our High-Throughput Drugs Discovery Core, High-Throughput Flow Cytometry Program, and MLOTS have relocated to a cutting-edge facility – the TMC3 Helix Park, Collaborative Building, located at 7255 Helix Park, Houston, TX 77030.

Get ready for expanded research opportunities, improved accessibility, and a wave of innovation at our new home. We're excited to continue our journey with you, fostering collaboration and groundbreaking discoveries.

Thank you for being an essential part of our success, and we look forward to welcoming you to our new facility at TMC3 Helix Park!


1. Our Core was featured on CPRIT 2021 annual report with two grants awarded a total of $10 million.
2. 2021 CPRIT award- Micro-physiological Lead Optimization and Toxicity Screening core facility (MLOTS).
3. 2022 Year-End Accomplishment.

2022YearEnd.png

GRANTS
  1. Core Grant Award
    1. CPRIT-RP200668 (2020), The Combinatorial Drug Discovery Program.
    2. CPRIT-RP210108 (2021), The GCC Microphysiological Lead Optimization and Toxicity Screening facility.
  2. Collaboration Grant Award
    1. CPRIT-RP190581(2019) with Dr. Margie Moczygemba, Gulf Coast Consortium High-throughput Flow Cytometry Program (HtFCP).
    2. NIH-NCI-1 U01 CA217613-01A1 (2020) with Dr. Xiao-nan Li, Matching panels of in vivo and in vitro model system of pediatric brain tumors.
    3. Texas A&M Seed Grant (2022) with Dr. Sanjukta Chakraborty, Development of a Lymph Node Tumor-on-a Chip (LnTOC) Screening Platform to Support Radiosensitizer Drug Discovery Research.
  3. Subcontract Grant Award
    1. NIH-NCI- R01CA241600 (2019) through Dr. Peter Davies with Dr. Frank McKeon from the University of Houston, Clonal Reconstruction and Targeting of the Correa Sequence.
    2. CPRIT- RP210108 (2022) with Dr. Humam Kadara from MDACC, Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer.

EVENTS
Dr. Reid Powell will attend the 2023 SLAS conference on Feb 28th @12pm to present The High-throughput Flow Cytometry Program (HtFCP) on BIO-RAD ZE5 Cell Analyzer integrated automation platform as well as our data analysis algorithm to provide an accurate and precise dataset for drug discovery. Follow our @TAMU_CDDP for an update on his presentation.